Technology Development in the Beyond Antibiotics programme, Institute of Biomedical Engineering, University of Oxford

The primary focus of our EPSRC Programme Grant Scheme funded research (EP/V026623/1) is the development of new technology to enable:

As recognised by the UN call-for-innovation, the creation of this technology represents a critical unmet need. To have a significant impact, it is essential that this development is also integrated with the wider global efforts on tackling AMR. We will achieve this through extensive engagement with AMR research networks and our clinical, industrial and policy partners. The aim within the 5 year programme is to provide a set of commercially viable and effective technologies to address the need for transformative innovation.